CTGF/Hcs24, hypertrophic chondrocyte-specific gene product, interacts with perlecan in regulating the proliferation and differentiation of chondrocytes

Journal of Cellular Physiology

Volumn 196, Issue 2, 2003, Pages 265-275

  Nishida, Takashi ^a   Kubota, Satoshi ^a   Fukunaga, Tomohiro ^a   Kondo, Seiji ^a   Yosimichi, Gen ^b   Nakanishi, Tohru ^a,b   Takano Yamamoto, Teruko ^a   Takigawa, Masaharu ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CONNECTIVE TISSUE GROWTH FACTOR; GENE PRODUCT; HEPARAN SULFATE; HEPARIN LYASE; PERLECAN; PROTEOGLYCAN;

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CELL METABOLISM; CELL PROLIFERATION; CHONDROSARCOMA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERTROPHY; IMMUNOFLUORESCENCE; IN VIVO STUDY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

AGED; ANIMALS; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CELL DIVISION; CHONDROCYTES; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN LYASE; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOLOGIC TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MALE; MICE; MICE, INBRED STRAINS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0038798680     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10277     Document Type: Article

References (54)

1. Abreu JG, Ketpura NI, Reversade B, De Robertis EM. 2002. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat Cell Biol 4:599-604.
2. Anderson HC, Hodges PT, Aguilera XM, Missana L, Moylan PE. 2000. Bone morphogenetic protein (BMP) localization in developing human and rat growth plate, metaphysis, epiphysis, and articular cartilage. J Histochem Cytochem 48:1493-1502.
3. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. 1999. Perlecan is essential for cartilage and cephalic development. Nat Gen 23:354-358.
4. 3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19:2958-2966.
5. Bessey O, Lowry OH, Brock MJ. 1946. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem 164:321-329.
6. Birch MA, Skerry TM. 1999. Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones. Bone 24:571-578.
7. Brigstock DR. 1999. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 20:189-206.
8. Brigstock DR, Steffen CL, Kim GY, Vegunta RK, Diehl JR, Harding PA. 1997. Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. J Biol Chem 272:20275-20282.
9. Chen C-C, Chen N, Lau LF. 2001. The angiogenic factors cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 276:10443-10452.
10. Costell M, Gustafsson E, Aszódi A, Mörgelin M, Bloch W, Hunziker E, Addicks K, Timpl R, Fässler R. 1999. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109-1122.
11. David G, Bai XM, Van der Schueren B, Cassiman J-J, Vas der Berghe H. 1992. Developmental changes in heparan sulfate expression: In situ detection with mAbs. J Cell Biol 119:961-975.
12. Enomoto M, Takigawa M. 1992. Regulation of tumor-derived and immortalized chondrocytes. In: Adolphe M, editor. Biological regulation of the chondrocytes. Boca Raton, FL: CRC Press. pp 321-338.
13. French MM, Smith SE, Akanbi K, Sanford T, Hecht J, Farach-Carson MC, Carson DD. 1999. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis, and perlecan chondrogenic activity in vitro. J Cell Biol 145:1103-1115.
14. Ghayor C, Herrouin JF, Chadjichristos C, Ala-Kokko L, Takigawa M, Pujol JP, Galera P. 2000. Regulation of human COL2A1 gene expression in chondrocytes: Indentification of C-Krox-responsive elements and modulation by phenotype alteration. J Biol Chem 275:27421-27438.
15. Govindraj P, West L, Koob TJ, Neame P, Doege K, Hassell JR. 2002. Isolation and identification of the major heparan sulfate proteoglycans in the developing bovine rib growth plate. J Biol Chem 277:19461-19469.
16. Handler M, Yurchenco PD, Iozzo RV. 1997. Developmental expression of perlecan during murine embryogenesis. Dev Dyn 210:130-145.
17. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y. 2002. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 227:36288-36295.
18. Hattori T, Kubota S, Yutani Y, Fujisawa T, Nakanishi T, Takahashi K, Takigawa M. 2001. Change in cellular localization of a rheumatoid arthritis-related antigen (ra-a47) with downregulation upon stimulation by inflammatory cytokines in chondrocytes. J Cell Physiol 186:268-281.
19. 3 integrins: An adhesion modulated by glycosaminoglycan. J Cell Biol 119:945-959.
20. Hirashima Y, Kobayashi H, Suzuki M, Tanaka Y, Kanayama N, Fujie M, Nishida T, Takigawa M, Terao T. 2001. Characterization of binding properties of urinary trypsin inhibitor to cell-associated binding sites on human chondrosarcoma cell line HCS-2/8. J Biol Chem 276:13650-13656.
21. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, Ikeda E, Takata S, Kobayashi K, Okada Y. 2002. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 16:219-221.
22. 3. J Biol Chem 274:24321-24327.
23. Kato Y, Iwamoto M. 1990. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J Biol Chem 265:5903-5909.
24. Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts CT, Jr., Rosenfed RG. 1997. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci 94:12981-12986.
25. Kobayashi H, Hirashima Y, Wei Sun G, Fujie M, Nishida T, Takigawa M, Terao T. 2000. Identity of urinary trypsin inhibitor-binding protein to link protein. J Biol Chem 275:21185-21191.
26. Kubota S, Hattori T, Shimo T, Nakanishi T, Takigawa M. 2000. Novel intracellular effects of human connective tissue growth factor expressed in cos-7 cells. FEBS Lett 474:58-62.
27. Kubota S, Eguchi T, Shimo T, Nishida T, Hattori T, Kondo S, Nakanishi T, Takigawa M. 2001. Novel mode of processing and secretion of connective tissue growth factor/ecogenin (CTGF/Hcs24) in chondrocytic HCS-2/8 cells. Bone 29:155-161.
28. Lau LF, Lam SC-T. 1999. The CCN family of angiogenic regulators: The integrin connection. Exp Cell Res 248:44-57.
29. Molténi A, Modrowski D, Hott M, Marie PJ. 1999. Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro. Bone 24:337-347.
30. Moussad EE, Brigstock DR. 2000. Connective tissue growth factor: What's in a name? Mol Genet Metab 71:276-292.
31. Nakanishi T, Kimura Y, Tamura T, Ichikawa H, Yamaai Y, Sugimoto T, Takigawa M. 1997. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem Biophys Res Commun 234:206-210.
32. Nakanishi T, Nishida T, Shimo T, Kobayashi K, Kubo T, Tamatani T, Tezuka K, Takigawa M. 2000. Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology 141:264-273.
33. Nishida T, Nakanishi T, Shimo T, Asano M, Hattori T, Tamatani T, Tezuka K, Takigawa M. 1998. Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochem Biophys Res Commun 247:905-909.
34. Nishida T, Nakanishi T, Asano M, Shimo T, Takigawa M. 2000. Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol 184:197-206.
35. Nishida T, Kubota S, Nakanishi T, Kuboki T, Yosimichi G, Kondo S, Takigawa M. 2002. CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, stimulates proliferation and differentiation, but not hypertrophy of cultured articular chondrocytes. J Cell Physiol 192:55-63.
36. Noonan DM, Fulle A, Valente P, Cai S, Horigan E, Sasaki M, Yamada Y, Hassell JR. 1991. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 266:22939-22947.
37. Redini F, Galera P, Mauviel A, Loyau G, Pujol JP. 1988. Transforming growth factor β stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes. FEBS Lett 234:172-176.
38. Sakai T, Kambe F, Mitsuyama H, Ishiguro N, Kurokouchi K, Takigawa M, Iwata H, Seo H. 2001. Tumor necrosis factor α induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-κB: Abrogation of the tumor necrosis factor α effect by proteasome inhibitors. J Bone Miner Res 16:1272-1280.
39. Salter DM, Godolphin JL, Gourlay MS. 1995. Chondrocyte heterogeneity: Immunohistologically defined variation of integrin expression at different sites in human fetal knees. J Histochem Cytochem 43:447-457.
40. 2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 276:40659-40667.
41. Shimo T, Nakanishi T, Kimura Y, Nishida T, Ishizeki K, Matsumura T, Takigawa M. 1998. Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem 124:130-140.
42. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T, Takigawa M. 1999. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 126:137-145.
43. SundarRaj N, Fite D, Ledbetter S, Chakravarti S, Hassell JR. 1995. Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. J Cell Sci 108:2663-2672.
44. Takigawa M. 2000. Physiological roles of connective tissue growth factor (CTGF/Hcs24): Promotion of endochondral ossification, angiogenesis, and tissue remodeling. In: Ikada Y, Shimizu Y, editors. Tissue engineering for therapeutic use 4: 1999. Amsterdam: Elsevier. pp 1-13.
45. Takigawa M, Tajima K, Pan H-O, Enomoto M, Kinoshita A, Suzuki F, Takano Y, Mori Y. 1989. Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes. Cancer Res 49:3996-4002.
46. Takigawa M, Pan H-O, Kinoshita A, Tajima K, Takano Y. 1991. Establishment from a human chondrosarcoma of a new immortal cell line with high tumorigenicity in vivo, which is able to form proteoglycan-rich cartilage-like nodules and to respond to insulin in vitro. Int J Cancer 48:717-725.
47. Takigawa M, Okawa T, Pan H-O, Aoki C, Takahashi K, Zue J-D, Suzuki F, Kinoshita A. 1997. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8. Endocrinology 138:4390-4400.
48. Tamatani T, Kobayashi H, Tezuka K, Sakamoto S, Suzuki K, Nakanishi T, Takigawa M, Miyano T. 1998. Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem Biophys Res Commun 251:748-752.
49. Tamura T, Nakanishi T, Kimura Y, Hattori T, Sasaki K, Norimatsu H, Takahashi K, Takigawa M. 1996. Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: A possible mechanism of pathological neovascularization in arthritis. Endocrinology 137:3729-3737.
50. Trippel SB. 1992. Role of insulin-like growth factors in the regulation of chondrocytes. In: Adolphe M, editor. Biological regulation of the chondrocytes. Boca Raton, FL: CRC Press. pp 161-190.
51. Tsuji M, Funahashi S, Takigawa M, Seiki M, Fujii K, Yoshida T. 1996. Expression of c-fos gene inhibits proteoglycan synthesis in transfected chondrocyte. FEBS Lett 381:222-226.
52. 1-fibronectiin bridge. J Cell Sci 107:993-1005.
53. Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M. 2001. CTGF/Hcs24 induced chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 268:6058-6065.
54. Zhu JD, Pan H-O, Suzuki F, Takigawa M. 1994. Proto-oncogene expression in a human chondrosarcoma cell line: HCS-2/8. Jpn J Cancer Res 85:364-371.